Entag, Lorna G.

HRN: 29-08-39  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/31/2026
CEFTRIAXONE 1G (VIAL)
05/31/2026
06/07/2026
IVTT
2g
OD
INFECTED WOUND
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines